Swiss pharmaceutical company Roche has nominated Christophe Weber, former Representative Director, President and CEO of Takeda Pharmaceutical Company Limited, as a director. He is expected to take office after the proposal is approved at the shareholders’ meeting on 9 March 2027.
Roche announced that it had nominated Weber, former CEO of Takeda Pharmaceutical Company Limited, as a director. He is expected to take office if approved at the shareholders’ meeting scheduled for 9 March 2027.
Weber is expected to assume a new position as a director of Roche, with his appointment to take effect after approval at the shareholders’ meeting.